Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
Keywords: 2-Arylbenzimidazoles; Pyrazoles; Chk2 inhibitors; Cell cycle; Genotoxic anticancer therapies;